Next Article in Journal
Rice Industry By-Products as Adsorbent Materials for Removing Fluoride and Arsenic from Drinking Water—A Review
Previous Article in Journal
Reservoir Performance Prediction in Steam Huff and Puff Injection Using Proxy Modelling
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Applied Sciences
Volume 12
Issue 6
10.3390/app12063170
applsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Delving into the Nutraceutical Benefits of Purple Carrot against Metabolic Syndrome and Cancer: A Review

by
Hina Rasheed
1,†,
Maham Shehzad
1,†,
Roshina Rabail
1,
Przemysław Łukasz Kowalczewski
2,*,
Marcin Kidoń
2,
Paweł Jeżowski
3,
Muhammad Modassar Ali Nawaz Ranjha
4,
Allah Rakha
1,
Ahmad Din
1,* and
Rana Muhammad Aadil
1,*
1
National Institute of Food Science and Technology, University of Agriculture, Faisalabad 38000, Pakistan
2
Department of Food Technology of Plant Origin, Poznań University of Life Sciences, 60-624 Poznań, Poland
3
Institute of Chemistry and Technical Electrochemistry, Poznan University of Technology, 60-965 Poznań, Poland
4
Institute of Food Science and Nutrition, University of Sargodha, Sargodha 40100, Pakistan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Appl. Sci. 2022, 12(6), 3170; https://doi.org/10.3390/app12063170
Submission received: 14 February 2022 / Revised: 16 March 2022 / Accepted: 18 March 2022 / Published: 20 March 2022
(This article belongs to the Section Food Science and Technology)
Browse Figures
Versions Notes

Abstract

:
Metabolic syndrome (MetS) constitutes a group of risk factors that may increase the risk of cancer and other health problems. Nowadays, researchers are focusing on food compounds that could prevent many chronic diseases. Thus, people are shifting from dietary supplements towards healthy nutritional approaches. As a nutritious and natural food source, purple carrot (Daucus carota spp. Sativus var. atrorubens Alef.) roots could have an important role in the prevention of MetS as well as cancer. This review provides deep insight into the role of purple carrot’s main bioactive compounds and their effectiveness against MetS and cancer. Phenolic compounds, such as anthocyanin, present in purple carrot roots may be especially productive in avoiding or delaying the onset of cardiovascular disease (CVDs), obesity, diabetes, and cancer. Anthocyanins and other phenolics are successful in reducing metabolic changes and inflammation by inhibiting inflammatory effects. Many researchers have made efforts to employ this vegetable in the prevention and treatment of MetS and cancer. However, more advanced studies are required for the identification of its detailed role, effectiveness, suitable intake, and the effect of its bioactive compounds against these diseases.

1. Introduction

Nowadays, we know more and more about the genesis and causes of many chronic diseases. Certain interconnected factors could predispose to type 2 diabetes and cardiovascular disease and currently are defined as metabolic syndrome (MetS). The main considered factors are dyslipidemia (high levels of low-density lipoprotein (LDL), triglycerides (TG), and low levels of high-density lipoprotein (HDL)), high blood pressure, obesity, impaired glucose metabolism, and/or insulin resistance [1,2]. Although it is diagnosed based on at least any three metabolic changes, the most common features of the pathophysiology of MetS are insulin resistance and visceral adiposity [3]. The pathogenic processes of MetS are complex and still debated. The geographic diversity in MetS distribution highlights the importance of environmental and lifestyle factors as major causes. Most of the mechanisms are triggered by visceral adiposity. However, major contributors to the onset, progression, and transition of MetS to cardiovascular diseases (CVD) are neurohormonal activation, insulin resistance, and inflammation [4]. It is considered that MetS could considerably increase personal healthcare costs and be an important risk factor for mortality in most developed countries [5].
Another serious public health issues across the world is cancer [6]. The link between MetS and cancer mortality is of particular concern. MetS could be associated with cancer because it increases cancer risk and cancer-related mortality; also, cancer survivors are more likely to develop MetS [7]. MetS and cancer are chronic and biologically complex diseases with numerous modifiable and non-modifiable risk factors in common [8]. However, a study indicated that in MetS patients adipose tissue is characterized by dysregulation of cytokine production, which may result in chronic inflammation. This inflammation, as well as its mediators, could have a role in tumor formation [9]. As, the term “cancer” covers a large group of diseases, but common features of cancers are uncontrolled growth and division of cells. The most common cancers are breast, lung, colon and rectal and prostate cancers. Deaths caused by cancer are estimated at nearly 10 million per year and it is the leading cause of death worldwide [10].
Lifestyle, as well as environmental and genetic factors, could increase the risk of developing cancer and MetS [11]. Alcohol consumption has remained a prominent cause behind the prevalence of MetS but the link however is still controversial [12]. Similarly smoking has remained a major risk factor for overweight and abdominal obesity in older people [13]. Overweight and obesity is one of the significant risk factors for MetS and a worldwide challenge for nutrition [14], affecting both children and adults [15]. MetS is a valuable clinical tool for predicting diabetes and cardiovascular disease, particularly in high-risk individuals with MetS [16]. In addition, MetS has shown associations with diverticulosis (bowel disease), in a univariate analysis for age, increased waist circumference, hypertension, and hyperlipidemia [17].
Numerous studies have found significant gene–environment interactions in the etiology of obesity as well in the pathogenesis of type 2 diabetes and coronary heart disease [18]. Individual genetic predispositions and environmental circumstances work together to support or hinder cellular processes. Complications emerge as a result of accumulated genetic and environmental risk factors, impacting health and reducing lifespan [19]. The single-nucleotide polymorphism (SNP) rs662799 in the APOA5 (apolipoprotein A5) gene is associated with an increased risk of MetS and its components [20]. Moreover, data have revealed that the adiponectin rs266729 gene polymorphism is reduced in colorectal cancer patients, implying that lower levels may be a significant risk factor for colorectal cancer in MetS patients [21].
Figure 1 demonstrates the factors affecting MetS and cancer. Although the burden of cancer rises at all human development index (HDI) levels, the epidemiological transition of cancer in developing HDI countries is anticipated to be the most affected. Many nations with low and medium HDI levels are seeing a significant increase in the incidence of known cancer risk factors that are also prevalent in high-income western countries (e.g., smoking, excess body weight, bad eating habits and physical inactivity). However, substantial work should be done to incorporate current effective interventions into existing health strategies as well as to cultivate novel interventions that either address global exposure or cancers with few preventative options [22].
Unfortunately, the prevalence of MetS is escalating worldwide [23]. It can also be noticed in developing countries due to sudden shifts in dietary habits and lifestyle patterns [24]. Globally, MetS ranges from 10–85%. Epidemiological studies highlighted that MetS probability increases with age [25]. It was reported to have a prevalence of 24.3% in Europe, with the chances of occurrence gradually increasing from 3.7% in <30-year-old to <30% in ≥70-year-old subjects [3]. Prevalence rates differ due to the presence of multiple criteria in its diagnosis. Therefore, it is accepted that as body mass index (BMI) and age increase, the incidence of MetS usually grows [26]. Although the prevalence of MetS was reportedly high (65.5%), it was observed that the occurrence of MetS was associated with acute and severe coronary artery disease [27] and may also increase the chances of CVD and diabetes [28]. The combined prevalence of overweight (>85th percentile) and obesity (>95th percentile) is 31%. Thus, sufficient and balanced nutrient consumption has been the main factor in prevention strategies. In the present era, the consumption of refined and processed foods could have contributed to the progression of MetS [24]. Research highlights that metabolic parameters (fasting blood glucose, abnormal lipid profile, and waist circumference) are greatly affected by diet and physical activity levels [29]. Increased consumer awareness has also altered consumption profiles. Foods and certain specific dietary components have recently gained a lot of attention in the treatment of MetS. In this regard, fruits and vegetables have been demonstrated to have health-promoting properties, making them promising sources of polyphenols [30]. Carrots are becoming more widely available plants in the midst of growing health concerns [31]. Due to higher production and utilization as a fresh and processed product, carrots are the most significant nutritive plants and are ranked among the top 10 plant crops in the world [32]. Among different colored carrot cultivars, the most well-known are orange. Purple (black) carrot varieties (Daucus carota ssp. sativus var. atrorubens Alef.) are not so popular, but in some countries are still traditionally cultivated and consumed. Purple carrot roots are a rich source of nutrients, especially phenolic compounds, anthocyanins, and carotenoids. All of these may play a potent role in reducing the risk of chronic diseases. Based on a number of available studies, an evaluation of the effects of purple carrots on MetS and cancer was undertaken. The present review is based on in vitro, in vivo, and clinical studies and attempts to clarify the mechanisms of action and the importance of particular compounds in purple carrots.

2. Purple Carrot and Its Nutritional Value

Carrots (Daucus carota L.) belong to the family Apiaceae [33]. Orange varieties represent the majority of carrot production (Daucus carota ssp. sativus var. atrorubens Alef.), though in some regions, such as Turkey, Afghanistan, Egypt, and India, purple carrot varieties are traditionally grown and consumed. Purple carrot roots have a bluish-purple color associated with the presence of a high number of anthocyanins. Due to the constraints on artificial additives and the growing demand for natural antioxidants, these pigments have recently received more interest as a natural food colorant [34]. The utilization of natural food colorants from purple carrots has increased because of the high stability of the acylated anthocyanins they contain [35]. Similarly, many studies have demonstrated that purple carrot roots contain high numbers of phenolics as compared with other colored vegetables [36]. Table 1 presents the average nutritional values of purple carrot roots per 100 g FW. Purple carrots contain significant quantities of carbohydrates, vitamins, minerals, and anthocyanins. Therefore, they are considered to be a valuable vegetable with a rich nutritional profile [37].
Table 2 presents some bioactive compounds present in purple carrot roots. The dietary importance of carrots due to a range of phytochemicals, mainly phenolic compounds, carotenoids, polyacetylenes, and dietary fiber [39]. Purple carrot cultivars contain high amounts of phenolic compounds as compared to other colored varieties [40]. The total phenolic content of purple carrot roots could range from 43.31 to 76.64 [41] mg/100 g fresh weight (FW), of which 78% are anthocyanins, 18% phenolic acids and 4% other flavonoids [42]. Moreover, purple carrot roots are an interesting natural food source, due to the high levels of polyphenols, particularly anthocyanins and phenolic acids, all of which make a significant contribution to biological activities [42]. Furthermore, 5-O-caffeoylquinic acid is an important phenolic acid present in purple carrot roots. Additionally, these carrots contain some derivatives of hydroxybenzoic acid, quercetin, ferulic, and caffeic acid. Two non-acylated anthocyanins (cyanidin-3-xylosyl glucosyl galactoside and cyanidin-3-xylosylgalactoside) and three mono-acylated anthocyanins (cyanidin-3-xylosylgalactoside, feruloyl glucosyl galactoside, and coumaroyl-glucosyl galactoside) have been quantified and recognized in purple carrots in recent research [35]. Purple carrot is also a good source of carotenoids, mainly β- and α-carotenes and lutein. Its roots could contain 600–20,000 µg carotenoids per 100 g. These amounts could be higher than typical orange varieties [41,43,44].

3. Purple Carrot and Prevention of MetS and Cancers

Purple carrot and its bioactive compounds show a protective effect against various diseases (cancer, CVD, obesity, diabetes) [31]. Especially due to their high nutritive values and good storage attributes, carrots play a major role in fiber and nutrition provision to the body [52]. The current study highlights the prospects of purple carrot polyphenols for health promotion.
Table 3 shows the potential contributions of purple carrot constituents in relation to MetS and cancer.
It has been documented that in animals, anthocyanins and phenolic acids were successful in reducing metabolic changes and inflammation by inhibiting inflammatory markers [56]. Moreover, polyacetylenes derived from plant extracts are known for their health-promoting properties, and in vitro results indicate their anti-inflammatory [57] and anti-cancer potential. Similarly, they also exhibit anticoagulant, antifungal, and anti-inflammatory actions [58]. Meanwhile, bioavailable polyphenols are reported to potentially counteract the harmful effects of elevated blood triglyceride levels and are considered beneficial health compounds that can minimize the risk of cardiovascular disease [51]. In obese rats, it was hypothesized that substituting purple carrot and purple potato for carbohydrates would improve blood pressure and insulin resistance, the main components of MetS [59]. Another study supports the stated metabolic health benefits of purple carrots and potatoes, confirming that these vegetables are effective replacements for other simple carbohydrate sources for improved metabolic health [60].
Anthocyanins (cyanidin, petunidin, delphinidin) may have a preventive role against various diseases, are a proven source of cyanidin-based pigment and protect against certain forms of malignancies [61,62]. Furthermore, combined treatments with two or three antioxidants demonstrated higher antioxidant activity as compared to individual treatments, implying that anthocyanins from purple carrots could have synergistic effects with other antioxidant compounds, for example, carotenoids. Synergistic effects of antioxidants were found in rats suffering from D-galactose-induced oxidative damage [63]. Due to the presence of anthocyanins, purple carrots can inhibit cancer cell proliferation [64]. As purple carrot anthocyanins reach the colon in an intact or modified form, they have shown an ability to protect colon cells against oxidative stress [62].
Park et al. [46] found that purple carrot anthocyanins could alleviate menopause symptoms by preventing the exacerbation of lipid and glucose metabolism via activation of hepatic insulin signaling and AMP kinase activation. Purple carrot extract, especially obtained after fermentation by Lactobacillus plantarum or Aspergillus oryzae, substantially reduced lipid adiposity in 3T3-L1 cell lines of adipocytes by enhancing the expression of carnitine palmitoyltransferase-1 (CPT-1) and reducing fatty acid synthase (FAS) and sterol regulatory element-binding protein-1c (SREBP) levels in rats. Figure 2 is a graphical representation of the nutraceutical benefit of purple carrot against MetS and cancer.

3.1. Anti-Diabetic Potential of the Purple Carrot

It has recently been proposed that purple carrot compounds can influence the metabolism of glucose. Anthocyanins from purple carrot, especially cyanidin 3-xylosyl galactoside, were found to be good inhibitors of α-amylase, α-glucosidase, and dipeptidyl peptidase IV [65]. Kaeswurm et al. [66] also found that α-glucosidase inhibition is not significantly affected by the glycosidic side of cyanidin chains (monoglucoside has a similar effect compared to diglicoside). However, a markedly stronger action of the acylated structures compared to anthocyanin-3-glycosides was found. About 58% of purple carrot anthocyanins are present in an acylated form [66,67]. Not only anthocyanin but also other phenolic compounds could affect carbohydrate digestion enzymes. As proved by Esatbeyoglu et al. [45], phenolic acid from purple carrot fractions (containing mainly chlorogenic acid) was the strongest α-amylase inhibitor. Moreover, purple carrot extract caused a moderate inhibition of intestinal glucose uptake in Caco-2 cells. The authors did not observe impaired Caco-2 and enteroendocrine GLUTag cell viability due to purple carrot extract up to a concentration of 100 μg/mL or 50 μg/mL, respectively.
These properties could be associated with slowing down glucose absorption and metabolism. Inhibition of these enzymes involved in carbohydrate digestion could therefore partially reduce postprandial blood glucose levels and prevent hyperglycemia [45].
It was found that increased insulin resistance in body tissues could be associated with type 2 diabetes development. Fermented extracts of purple carrot with Aspergillus oryzae and Lactobacillus plantarum exhibit strong anti-diabetic potential by preventing insulin resistance. They also improved first-phase insulin secretion and insulin sensitivity in the hyperglycemic state in type 2 diabetic rats with dementia [68,69].
Another study based on animal models explained and assessed purple carrot phenolic compound contributions in antioxidant defense, glucose metabolism, and renal and hepatic toxicity in rats. The positive effects of thirty days of consumption of purple carrot juice were a significant reduction in blood triglyceride concentration and superoxide dismutase activity in both dose-dependent and time-dependent manners. Therefore, no major impact on blood glucose concentration and no toxicity was observed concerning the functioning of the kidneys and liver [35]. Additionally, Dragano et al. [70] conducted a study that demonstrated the effectivity of anthocyanin-rich supplementation in the reduction of insulin resistance by improving signal transduction using the insulin receptor substrate-1/Akt pathway in adipose tissue. Similarly, anthocyanins also lower insulin resistance by decreasing insulin concentrations in blood [71].

3.2. Anti-Obesity and Cardioprotective Potential of Purple Carrot

Purple carrot’s bioactive compounds, especially phenolic compounds and anthocyanins, could considerably reduce the risk of cardiovascular disease and cancer [72]. It was established by others that high serum triglycerides and elevated blood pressure could contribute to CVD [73]. It was proved in a human study that consumption of 200 g of purple carrot (containing 700 mg of cyjanidin-3-glicoside) per day for 12 weeks may decrease serum triglyceride levels and reduce systolic and diastolic blood pressure in individuals at risk for cardiovascular disease [73]. Another human trial confirmed that consumption of purple carrot containing 18.5 mg/day of anthocyanins and 259.2 mg/day of phenolic acids for 4 weeks lowered high-density lipoprotein cholesterol levels. Although the intake of purple carrots did not affect other body parameters, such as mass, body composition, appetite, dietary intake, low density lipoprotein, total cholesterol, blood pressure, or C-reactive protein, its consumption could be considered safe. Aspartate amino transferase and alanine amino transferase in humans did not change after consumption of dried purple carrot reconstituted in water equivalent to approximately 300 g fresh carrot per day for 4 weeks, allowing the conclusion that purple carrot consumption did not cause hepatoxic problems [74].
There is also an animal study of purple carrot anthocyanin and phenolic effectiveness in obesity and cardiovascular risk prevention. The study conducted by Poudyal et al. [56] demonstrated that treatment of diet-induced MetS in rats with purple carrot juice attenuated or reversed the changes in cardiovascular and liver structure and functions as well as in metabolic parameters, especially abdominal fat deposition and plasma lipid profiles. Obesity is a major public health concern around the world, which increases the risk of cardiovascular disease and disrupts blood glucose homeostasis. Purple carrot anthocyanins and phenolic acids help reduce inflammation and metabolic changes in animal models, possibly through inhibiting inflammatory pathways. A randomized controlled trial was conducted to investigate the effect of dried purple carrot on body composition, body mass, blood pressure, lipids profile, inflammatory markers, and hepatic function. There were no statistically significant changes. The levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) remained unchanged, indicating that the treatment was safe [75]. Higher anthocyanin intake was linked to considerably reduced systolic blood pressure in a cross-sectional study of 1997 females conducted in the United Kingdom [71]. Likewise, in another cross-sectional study, higher serum HDL levels were observed due to intake of anthocyanidins, which reflect better lipid profiles [63]. The authors also assigned this effect to anthocyanins present in purple carrot juice, because in their study β-carotene did not reduce oxidative stress, cardiac stiffness, or hepatic fat deposition and the pressed carrot juice itself contained a low concentration of carotenoids.

3.3. Anti-Inflammatory and Anti-Cancer Potential of Purple Carrot

Compounds with antioxidant activity could play important roles in the prevention of many health problems, such as carcinogenesis, aging, metabolic events, immune disorders, and neurodegenerative diseases. Some studies have suggested that purple carrot bioactive compounds possess anti-inflammatory and anti-cancer potential.
Blando et al. [76] conducted a study to investigate the biological activity and antioxidant potential of purified anthocyanin from different anthocyanin-rich plants. The findings showed that biological and antioxidant activity was seen in all tested purified anthocyanin samples differing in anthocyanin content (from 4.9 to 38.5 mg/g DW). Different anthocyanins exerted radical scavenging activity of various magnitudes, and this was higher in samples containing non-acylated anthocyanins. Accordingly, purified anthocyanins decreased endothelial inflammatory antigen expression, indicating a possible beneficial impact in cardiovascular protection. That effect was also dependent on structural differences in anthocyanins; non-acylated forms were more effective than anthocyanins acylated with cinnamic acid derivatives.
Some nutrients present in purple carrots could be considered as anticancer agents, for instance, carotenoids, which could be easily provided by consumption of purple carrots. High concentrations of carotenoids are inversely proportional to oxidative stress in the human body. Butalla et al. [77] have highlighted in their work that intake of purple carrot juice is an easy and efficient way of enhancing the total carotenoid content in blood plasma. These authors conducted a randomized intervention study among breast cancer survivors with obesity (the BMI of participants ranged from 25 to 45). For 3 weeks, participants consumed about 240 mL of purple carrot juice (which corresponded to about 5 carrot roots). This intervention led to a statistically significant increase in carotenoid content in blood plasma. At the same time, the content of 8-iso-PGFα, which is an indicator of oxidative stress in the human body, was decreased. High carotenoid contents and low 8-iso-PGFα levels in blood plasma may lead to a reduced risk of cancer recurrence.
Anthocyanins from purple carrot could also possess anticancer, antioxidant and chemoprotective properties. Jing et al.’s [78] research showed that the aqueous extract of purple carrot anthocyanins effectively reduced human colorectal adenocarcinoma cell (HT-29) line growth. Non-acylated anthocyanins were more effective than acylated ones; the suppressive effects of purple carrot anthocyanins were stronger than those of radish or elderberry.
A study conducted by Sevimli-Gur [54] considered the cytotoxic activity of purple carrot calli extract against different cancer cells in humans. The lowest IC50 values against MCF-7, SK-BR-3, and neuro-2A cell lines were obtained. However, low cytotoxicity in the normal cell line VERO was achieved, suggesting that purple carrot phenolics are a superior option which do not cause negative effects in normal healthy cells.
Purple carrot polyphenols effectively downregulated the secretion of certain pro-inflammatory markers, namely, interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), and intercellular adhesion molecule-1 (ICAM-1), under normal and TNF-α-induced inflammatory conditions. Better functionality was achieved after extract digestion compared to undigested extract. After digestion, the phenolic profile of purple carrot was similar to undigested carrot, but digestion increased the amounts of transported anthocyanins and phenolic acids through Caco-2 monolayers by about two times. The study suggested that anthocyanins are transported in intact glycone form and that increasing their concentration could not change absorption efficiency and lead to saturation of the absorption mechanism [79].
Purple carrot extracts also downregulated other proinflammatory factors, such as interleukins Il-1β (decrease by 91%) and Il-6 (decrease by 69%), as well as inflammatory mediators, such as cyclooxygenase-2 (Cox-2) and inducible nitric oxide synthase (iNos) [57], in lipopolysaccharide-activated RAW264.7 cells. The important point is that anthocyanins, even in an acylated form, were able to cross the intestinal barrier and may potentially contribute to health effects in other tissues in the human body [57].
Research suggests that purple carrot compounds could be useful for the treatment of liver injury caused by alcohol. Purple carrot extract recovered the cell viability of in vitro ethanol-treated hepatocytes. The butanol fraction of purple carrot extract was able to scavenge reactive oxygen species induced by ethanol. Moreover, this fraction also regulated the activities of three alcoholic metabolism-related enzymes: cytochrome P450 2E1 activity was suppressed and alcohol dehydrogenase and aldehyde dehydrogenase activities were increased. The butanol fraction of purple carrot extract could also increase cyclic adenosine 3′,5′-monophosphate concentration by suppressing the expression of phosphodiesterase 4b mRNA. The authors suggested that polyphenols and anthocyanin pigments extracted from purple carrots in considerable amounts were responsible for this effect [80].
Data also indicated that certain phytochemicals (carotenoids, polyacetylenes, phenolics, sesquiterpenes, iso-coumarins, and anthocyanins) exhibited potential against inflammation, reducing nitric oxide production by up to 65% without causing any cytotoxicity, and also played an important role in the reduction of pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and iNOS (in macrophage cells) [81]. In another study, it was proposed that the bioactive components of carrots (polyacetylenes) were effective in the treatment of leukemia despite beta-carotenes or lutein [82]. The anticancer effect of purple carrot extracts was determined against breast cancer cell lines (MCF-7) by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) assay. The results showed that acetone and ethanol extracts of purple carrot (50 μg/mL) demonstrated 8.13% and 30.6% inhibition of breast cancer cell lines, respectively. These findings demonstrated that purple carrot extracts contain bioactive compounds that are effective against breast cancer [37].
Likewise, the effect of purple carrot extract anthocyanins on encapsulation with halloysite nanotubes (HNT) indicated that the percentage of anthocyanins loaded into the nanotubes was 4% by weight. Compared to pure anthocyanins, anthocyanin-containing HNTs displayed strong anti-proliferative potential against cancer cells, such as HT-29 and MCF-7 [83].
Another study was designed in which the cytotoxic potential of purple carrot anthocyanin extract was assessed against bone osteosarcoma, neuroblastoma, breast adenocarcinoma, and alveolar adenocarcinoma. In most cell lines, cytotoxic activity was remarkable, with IC50 values < 5.5 mg/mL [84]. Another recent in vivo study was conducted on male rats, proposing that carrot juice attenuates circulatory free fatty acids and inflammatory markers, while MCP1 and hsCRP levels induced by a high fructose diet did not have an effect on the adiposity of the abdomen or the cell size of organ fat deposits [61].
In a study of black carrot crude extract (BCCE), it was also found that phenolic contents positively correlated with antioxidant activity and anti-angiogenic cytoprotective properties. Purple carrots are recognized as a functional food owing to their high content of phenolic acid, flavonols, flavanol, and flavanones, all of which make a significant contribution to biological activities. Moreover, the employment of nutraceutical-like (BCCE) avoids the onset of diseases linked to oxidative stress [42]. In addition, a study investigated the chemopreventive potential of purple carrot extract after 4-nitroquinoline 1-oxide induced carcinogenesis in rat tongues. A total of 20 male rats were divided into four groups (n = 5 in each group). The research was carried out for 12 weeks. The antioxidant activity, anti-inflammatory potential and antiproliferative and antimutagenic properties of purple carrot extract protected rats from oral lesions [17].
Anthocyanins are flavonoids with strong biological activity against a variety of malignancies, including colorectal cancer. The specific molecular mechanism through which anthocyanins fight cancer is unknown. Anthocyanins inhibited cell proliferation while promoting apoptosis in HT29 cells as compared to the control group. Anthocyanins boosted the apoptosis regulator (Bcl-2) protein coding gene and caspase-dependent apoptotic pathways by targeting the phosphoinositide 3-kinase (PI3K) pathway, causing colorectal cancer growth to be inhibited [85].
Furthermore, self-reported raw carrot intake of up to 2 to 4 or more carrots per week, more than 32 g/day, was linked with a 17% reduction in colorectal cancer (CRC) occurrence as compared to subjects without raw carrot intake. An intake of less than two to four carrots per week, less than 32 g/day, was not linked with CRC reduction [86]. Table 4 shows the impact of purple carrot consumption with regard to MetS and cancer.

4. Conclusions

Different research is directed towards food compounds to prevent and fight different diseases. Purple carrots (Daucus carota ssp. sativus var. atrorubens Alef) are a rich source of health-enhancing nutrients. The most important for targeting MetS and cancer seem to be phenolic compounds. There is a great deal of in vitro evidence that anthocyanins and other phenolics could improve the biochemical parameters of human cells. In addition, some human trials support the positive influence of purple carrot consumption. Carrots rich in anthocyanin content can improve blood pressure and serum triglyceride levels in people at risk of CVDs. Furthermore, while querying various databases, it was found that there are limited studies related to CVDs and obesity, so further research is required to identify the effectiveness, suitable intake of purple carrot, dosage, and the effectivity of its bioactive components against different diseases.

Author Contributions

Conceptualization, H.R., M.M.A.N.R. and R.M.A.; writing—original draft preparation, H.R., M.S. and R.R.; tables and figures preparation, R.R., P.Ł.K., M.M.A.N.R. and A.D.; writing—review and editing, P.Ł.K., M.K., P.J., A.R., A.D. and R.M.A.; supervision, R.M.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors are grateful to the University of Agriculture, Faisalabad, Pakistan, for support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Capomolla, A.S.; Janda, E.; Paone, S.; Parafati, M.; Sawicki, T.; Mollace, R.; Ragusa, S.; Mollace, V. Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols. Nutrients 2019, 11, 1271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kassi, E.; Pervanidou, P.; Kaltsas, G.; Chrousos, G. Metabolic syndrome: Definitions and controversies. BMC Med. 2011, 9, 48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Scuteri, A.; Laurent, S.; Cucca, F.; Cockcroft, J.; Cunha, P.G.; Mañas, L.R.; Raso, F.U.M.; Muiesan, M.L.; Ryliškytė, L.; Rietzschel, E.; et al. Metabolic syndrome across Europe: Different clusters of risk factors. Eur. J. Prev. Cardiol. 2015, 22, 486–491. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Matsuzawa, Y.; Funahashi, T.; Nakamura, T. The Concept of Metabolic Syndrome: Contribution of Visceral Fat Accumulation and Its Molecular Mechanism. J. Atheroscler. Thromb. 2011, 18, 1–11. [Google Scholar] [CrossRef] [Green Version]
  5. Ryckman, K.; Smith, C. Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome. Diabetes Metab. Syndr. Obes. Targets Ther. 2015, 8, 295–302. [Google Scholar] [CrossRef] [Green Version]
  6. Watanabe, J.; Kakehi, E.; Kotani, K.; Kayaba, K.; Nakamura, Y.; Ishikawa, S. Metabolic syndrome is a risk factor for cancer mortality in the general Japanese population: The Jichi Medical School Cohort Study. Diabetol. Metab. Syndr. 2019, 11, 1–12. [Google Scholar] [CrossRef]
  7. Bellastella, G.; Scappaticcio, L.; Esposito, K.; Giugliano, D.; Ida, M. Metabolic syndrome and cancer : ‘‘The common soil hypothesis ”. Diabetes Res. Clin. Pract. 2018, I, 389–397. [Google Scholar] [CrossRef]
  8. Reedy, J.; Krebs-smith, S.M.; Miller, P.E.; Liese, A.D.; Kahle, L.L.; Park, Y.; Subar, A.F. Higher Diet Quality Is Associated with Decreased Risk of All-Cause, Cardiovascular Disease, and Cancer Mortality among Older Adults. J. Nutr. Nutr. Epidemiol. 2014, 2, 881–889. [Google Scholar] [CrossRef] [Green Version]
  9. Braun, S.; Bitton-worms, K.; Leroith, D. The Link between the Metabolic Syndrome and Cancer. Int. J. Biol. Sci. 2011, 7, 1003–1015. [Google Scholar] [CrossRef]
  10. WHO. Cancer. 2022. Available online: https://www.who.int/news-room/fact-sheets/detail/cancer. (accessed on 13 February 2022).
  11. de, A. Boleti, A.; Almeida, J.; Migliolo, L. Impact of the metabolic syndrome on the evolution of neurodegenerative diseases. Neural Regen. Res. 2021, 16, 688. [Google Scholar] [CrossRef]
  12. Kim, S.K.; Hong, S.-H.; Chung, J.-H.; Cho, K.B. Association between Alcohol Consumption and Metabolic Syndrome in a Community-Based Cohort of Korean Adults. Clin. Res. 2017, 23, 2104–2110. [Google Scholar] [CrossRef] [Green Version]
  13. Wang, J.; Niratharakumar, K.; Gokhale, K.; Tahrani, A.A.; Taverner, T.; Thomas, G.N. Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study. Am. J. Kidney Dis. 2022, 79, 24–35.e1. [Google Scholar] [CrossRef] [PubMed]
  14. Afshin, A.; Forouzanfar, M.H.; Reitsma, M.B.; Sur, P.; Estep, K.; Lee, A.; Marczak, L.; Mokdad, A.H.; Moradi-Lakeh, M.; Naghavi, M.; et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years The GBD 2015 Obesity Collaborators. N. Engl. J. Med. 2017, 377, 1990. [Google Scholar]
  15. Ogden, C.L.; Carroll, M.D.; Lawman, H.G.; Fryar, C.D.; Kruszon-moran, D.; Kit, B.K.; Flegal, K.M. Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014. JAMA-J. Am. Med. Assoc. 2016, 315, 2292–2299. [Google Scholar] [CrossRef]
  16. Shin, J.; Lee, J.; Lim, S.; Ha, H.; Kwon, H.; Park, Y.; Lee, W.; Kang, M.; Yim, H.; Yoon, K.; et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J. Diabetes Investig. 2013, 4, 334–343. [Google Scholar] [CrossRef]
  17. Soares, G.R.; de Moura, C.F.G.; Silva, M.J.D.; Vilegas, W.; Santamarina, A.B.; Pisani, L.P.; Estadella, D.; Ribeiro, D.A. Protective effects of purple carrot extract (Daucus carota) against rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Med. Oncol. 2018, 35, 1–14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Andreassi, M.G. Metabolic syndrome, diabetes and atherosclerosis: Influence of gene – environment interaction. Mutat. Res. Mol. Mech. Mutagen. 2009, 667, 35–43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Pillon, N.J.; Loos, R.J.F.; Marshall, S.M.; Zierath, J.R. Metabolic consequences of obesity and type 2 diabetes : Balancing genes and environment for personalized care. Cell 2021, 184, 1530–1544. [Google Scholar] [CrossRef] [PubMed]
  20. Oh, S.; Lee, J.; Shin, E.; Kwon, H.; Choe, E.K.; Choi, S.-Y.; Rhee, H.; Choi, S.H. Genome-wide association study of metabolic syndrome in Korean populations. PLoS ONE 2020, 15, e0227357. [Google Scholar] [CrossRef]
  21. Divella, R.; Daniele, A.; Mazzocca, A.; Abbate, I.; Casamassima, P.; Ruggeri, E.; Naglieri, E.; Sabbà, C.; Luca, R. De ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer. J. Cancer 2017, 8, 1000–1008. [Google Scholar] [CrossRef] [Green Version]
  22. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [Green Version]
  23. Osei-Yeboah, J.; Owiredu, W.K.B.A.; Norgbe, G.K.; Yao Lokpo, S.; Gyamfi, J.; Alote Allotey, E.; Asumbasiya Aduko, R.; Noagbe, M.; Attah, F.A. The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study. Int. J. Chronic Dis. 2017, 2017, 1–8. [Google Scholar] [CrossRef] [Green Version]
  24. Misra, A.; Soares, M.J.; Mohan, V.; Anoop, S.; Abhishek, V.; Vaidya, R.; Pradeepa, R. Body fat, metabolic syndrome and hyperglycemia in South Asians. J. Diabetes Complicat. 2018, 32, 1068–1075. [Google Scholar] [CrossRef] [PubMed]
  25. Stout, M.B.; Justice, J.N.; Nicklas, B.J.; Kirkland, J.L. Physiological Aging: Links among Adipose Tissue Dysfunction, Diabetes, and Frailty. Physiology 2017, 32, 9–19. [Google Scholar] [CrossRef] [PubMed]
  26. Garralda-Del-Villar, M.; Carlos-Chillerón, S.; Diaz-Gutierrez, J.; Ruiz-Canela, M.; Gea, A.; Martínez-González, M.; Bes-Rastrollo, M.; Ruiz-Estigarribia, L.; Kales, S.; Fernández-Montero, A. Healthy Lifestyle and Incidence of Metabolic Syndrome in the SUN Cohort. Nutrients 2018, 11, 65. [Google Scholar] [CrossRef] [Green Version]
  27. Niazi, G.; Adnan, F.; Saleemi, M.; Akhtar, A.; Ahmed, N.; Shehzad, S. Severe Coronary Artery Disease and Metabolic Syndrome in Patients with Acute Coronary Syndrome in South Punjab Region of Pakistan. Eur. J. Cardiovasc. Med. 2020. [Google Scholar] [CrossRef]
  28. Herningtyas, E.H.; Ng, T.S. Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia. BMC Public Health 2019, 19, 377. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Huang, J.-H.; Li, R.-H.; Huang, S.-L.; Sia, H.-K.; Chen, Y.-L.; Tang, F.-C. Lifestyle Factors and Metabolic Syndrome among Workers: The Role of Interactions between Smoking and Alcohol to Nutrition and Exercise. Int. J. Environ. Res. Public Health 2015, 12, 15967–15978. [Google Scholar] [CrossRef] [Green Version]
  30. Tiwari, U.; Cummins, E. Factors in fluencing levels of phytochemicals in selected fruit and vegetables during pre- and post-harvest food processing operations. Food Res. Int. J. 2013, 50, 497–506. [Google Scholar] [CrossRef]
  31. Que, F.; Hou, X.-L.; Wang, G.-L.; Xu, Z.-S.; Tan, G.-F.; Li, T.; Wang, Y.-H.; Khadr, A.; Xiong, A.-S. Advances in research on the carrot, an important root vegetable in the Apiaceae family. Hortic. Res. 2019, 6, 69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Dawid, C.; Dunemann, F.; Schwab, W.; Nothnagel, T.; Hofmann, T. Bioactive C 17 -Polyacetylenes in Carrots (Daucus carota L.): Current Knowledge and Future Perspectives. J. Agric. Food Chem. 2015, 63, 9211–9222. [Google Scholar] [CrossRef] [PubMed]
  33. Erten, H.; Tanguler, H.; Canbaş, A. A Traditional Turkish Lactic Acid Fermented Beverage: Shalgam (Salgam). Food Rev. Int. 2008, 24, 352–359. [Google Scholar] [CrossRef]
  34. Ekici, L.; Ozturk, I.; Karaman, S.; Caliskan, O.; Tornuk, F.; Sagdic, O.; Yetim, H. Effects of black carrot concentrate on some physicochemical, textural, bioactive, aroma and sensory properties of sucuk, a traditional Turkish dry-fermented sausage. LWT-Food Sci. Technol. 2015, 62, 718–726. [Google Scholar] [CrossRef]
  35. Koley, T.K.; Srivastava, S.; Tripathi, Y.B.; Banerjee, K.; Oulkar, D.; Goon, A.; Tripathi, A.; Singh, B. High-Resolution LCMS Profiling of Phenolic Compounds of Indian Black Carrot and Evaluation of Its Effect on Antioxidant Defense and Glucose Metabolism in Animal Model. Agric. Res. 2019, 8, 481–489. [Google Scholar] [CrossRef]
  36. Leja, M.; Kamińska, I.; Kramer, M.; Maksylewicz-Kaul, A.; Kammerer, D.; Carle, R.; Baranski, R. The Content of Phenolic Compounds and Radical Scavenging Activity Varies with Carrot Origin and Root Color. Plant Foods Hum. Nutr. 2013, 68, 163–170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Saleem, M.Q.; Akhtar, S.; Imran, M.; Riaz, M.; Rauf, A.; Mubarak, M.S.; Bawazeer, S.; Bawazeer, S.S.; Hassanien, M.F. Antibacterial and anticancer characteristics of black carrot (Daucus carota) extracts. J. Med. Spice Plants 2018, 22, 40–44. [Google Scholar]
  38. Kamiloglu, S.; Van Camp, J.; Capanoglu, E. Black carrot polyphenols: Effect of processing, storage and digestion—An overview. Phytochem. Rev. 2018, 17, 379–395. [Google Scholar] [CrossRef]
  39. Ahmad, T.; Cawood, M.; Iqbal, Q.; Ariño, A.; Batool, A.; Tariq, R.M.S.; Azam, M.; Akhtar, S. Phytochemicals in Daucus carota and Their Health Benefits—Review Article. Foods 2019, 8, 424. [Google Scholar] [CrossRef] [Green Version]
  40. Yahia, E.M. Fruit and Vegetable Phytochemicals: Chemistry and Human Health, 2nd ed.; John Wiley & Sons: Hoboken, NJ, USA, 2017. [Google Scholar]
  41. Alasalvar, C.; Grigor, J.M.; Zhang, D.; Quantick, P.C.; Shahidi, F. Comparison of Volatiles, Phenolics, Sugars, Antioxidant Vitamins, and Sensory Quality of Different Colored Carrot Varieties. J. Agric. Food Chem. 2001, 49, 1410–1416. [Google Scholar] [CrossRef]
  42. Smeriglio, A.; Denaro, M.; Barreca, D.; D’Angelo, V.; Germanò, M.P.; Trombetta, D. Polyphenolic profile and biological activities of black carrot crude extract (Daucus carota L. ssp. sativus var. atrorubens Alef.). Fitoterapia 2018, 124, 49–57. [Google Scholar] [CrossRef]
  43. Lee, E.J.; Yoo, K.S.; Patil, B.S. Total carotenoid, anthocyanin, and sugar contents in sliced or whole purple (cv. Betasweet) and orange carrots during 4-week cold storage. Hortic. Environ. Biotechnol. 2011, 52, 402–407. [Google Scholar] [CrossRef]
  44. Luby, C.H.; Goldman, I.L. Release of Eight Open Source Carrot (Daucus carota var. sativa) Composite Populations Developed under Organic Conditions. HortScience 2016, 51, 448–450. [Google Scholar] [CrossRef] [Green Version]
  45. Esatbeyoglu, T.; Rodríguez-Werner, M.; Schlösser, A.; Liehr, M.; Ipharraguerre, I.; Winterhalter, P.; Rimbach, G. Fractionation of Plant Bioactives from Black Carrots (Daucus carota subspecies sativus varietas atrorubens Alef.) by Adsorptive Membrane Chromatography and Analysis of Their Potential Anti-Diabetic Activity. J. Agric. Food Chem. 2016, 64, 5901–5908. [Google Scholar] [CrossRef]
  46. Park, S.; Kang, S.; Jeong, D.-Y.; Jeong, S.-Y.; Park, J.J.; Yun, H.S. Cyanidin and malvidin in aqueous extracts of black carrots fermented with Aspergillus oryzae prevent the impairment of energy, lipid and glucose metabolism in estrogen-deficient rats by AMPK activation. Genes Nutr. 2015, 10, 6. [Google Scholar] [CrossRef]
  47. Blando, F.; Marchello, S.; Maiorano, G.; Durante, M.; Signore, A.; Laus, M.N.; Soccio, M.; Mita, G. Bioactive Compounds and Antioxidant Capacity in Anthocyanin-Rich Carrots: A Comparison between the Black Carrot and the Apulian Landrace “Polignano” Carrot. Plants 2021, 10, 564. [Google Scholar] [CrossRef]
  48. Purkiewicz, A.; Ciborska, J.; Tańska, M.; Narwojsz, A.; Starowicz, M.; Przybyłowicz, K.E.; Sawicki, T. The Impact of the Method Extraction and Different Carrot Variety on the Carotenoid Profile, Total Phenolic Content and Antioxidant Properties of Juices. Plants 2020, 9, 1759. [Google Scholar] [CrossRef] [PubMed]
  49. Christensen, L.P.; Kreutzmann, S. Determination of polyacetylenes in carrot roots (Daucus carota L.) by high-performance liquid chromatography coupled with diode array detection. J. Sep. Sci. 2007, 30, 483–490. [Google Scholar] [CrossRef] [PubMed]
  50. Baranska, M.; Schulz, H.; Baranski, R.; Nothnagel, T.; Christensen, L.P. In Situ Simultaneous Analysis of Polyacetylenes, Carotenoids and Polysaccharides in Carrot Roots. J. Agric. Food Chem. 2005, 53, 6565–6571. [Google Scholar] [CrossRef] [PubMed]
  51. Gu, C.; Suleria, H.A.R.; Dunshea, F.R.; Howell, K. Dietary Lipids Influence Bioaccessibility of Polyphenols from Black Carrots and Affect Microbial Diversity under Simulated Gastrointestinal Digestion. Antioxidants 2020, 9, 762. [Google Scholar] [CrossRef]
  52. Garba, U.; Kaur, S.; Gurumayum, S.; Rasane, P. Effect of Hot Water Blanching Time and Drying Temperature on The Thin Layer Drying Kinetics and Anthocyanin Degradation of Black Carrot (Daucus carota l.) Shreds. Food Technol. Biotechnol. 2015, 53, 324–330. [Google Scholar] [CrossRef]
  53. Xiao, J.B.; Hogger, P. Dietary Polyphenols and Type 2 Diabetes: Current Insights and Future Perspectives. Curr. Med. Chem. 2014, 22, 23–38. [Google Scholar] [CrossRef] [PubMed]
  54. Sevimli-Gur, C.; Cetin, B.; Akay, S.; Gulce-Iz, S.; Yesil-Celiktas, O. Extracts from Black Carrot Tissue Culture as Potent Anticancer Agents. Plant Foods Hum. Nutr. 2013, 68, 293–298. [Google Scholar] [CrossRef] [PubMed]
  55. Esposito, D.; Chen, A.; Grace, M.H.; Komarnytsky, S.; Lila, M.A. Inhibitory Effects of Wild Blueberry Anthocyanins and Other Flavonoids on Biomarkers of Acute and Chronic Inflammation in Vitro. J. Agric. Food Chem. 2014, 62, 7022–7028. [Google Scholar] [CrossRef]
  56. Poudyal, H.; Panchal, S.; Brown, L. Comparison of purple carrot juice and β-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br. J. Nutr. 2010, 104, 1322–1332. [Google Scholar] [CrossRef] [Green Version]
  57. Olejnik, A.; Kowalska, K.; Kidoń, M.; Czapski, J.; Rychlik, J.; Olkowicz, M.; Dembczyński, R. Purple carrot anthocyanins suppress lipopolysaccharide-induced inflammation in the co-culture of intestinal Caco-2 and macrophage RAW264.7 cells. Food Funct. 2016, 7, 557–564. [Google Scholar] [CrossRef]
  58. Baranska, M.; Roman, M.; Dobrowolski, J.C.; Schulz, H.; Baranski, R. Recent Advances in Raman Analysis of Plants: Alkaloids, Carotenoids, and Polyacetylenes. Curr. Anal. Chem. 2012, 9, 108–127. [Google Scholar] [CrossRef]
  59. Ayoub, H.M.; McDonald, M.R.; Sullivan, J.A.; Tsao, R.; Platt, M.; Simpson, J.; Meckling, K.A. The Effect of Anthocyanin-Rich Purple Vegetable Diets on Metabolic Syndrome in Obese Zucker Rats. J. Med. Food 2017, 20, 1240–1249. [Google Scholar] [CrossRef] [PubMed]
  60. Ayoub, H.M.; Mcdonald, M.R.; Sullivan, J.A.; Tsao, R.; Meckling, K.A. Proteomic Profiles of Adipose and Liver Tissues from an Animal Model of Metabolic Syndrome Fed Purple Vegetables. Nutrients 2018, 10, 465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Mahesh, M.; Bharathi, M.; Raja Gopal Reddy, M.; Pappu, P.; Putcha, U.K.; Vajreswari, A.; Jeyakumar, S.M. Carrot juice ingestion attenuates high fructose-induced circulatory pro-inflammatory mediators in weanling Wistar rats. J. Sci. Food Agric. 2017, 97, 1582–1591. [Google Scholar] [CrossRef] [PubMed]
  62. Olejnik, A.; Rychlik, J.; Kidoń, M.; Czapski, J.; Kowalska, K.; Juzwa, W.; Olkowicz, M.; Dembczyński, R.; Moyer, M.P. Antioxidant effects of gastrointestinal digested purple carrot extract on the human cells of colonic mucosa. Food Chem. 2016, 190, 1069–1077. [Google Scholar] [CrossRef]
  63. Li, X.; Zhang, Y.; Yuan, Y.; Sun, Y.; Qin, Y.; Deng, Z. Protective Effects of Selenium, Vitamin E, and Purple Carrot Anthocyanins on D -Galactose-Induced Oxidative Damage in Blood, Liver, Heart and Kidney Rats. Biol. Trace Elem. Res. 2016, 173, 433–442. [Google Scholar] [CrossRef] [PubMed]
  64. Netzel, M.; Netzel, G.; Kammerer, D.R.; Schieber, A.; Carle, R.; Simons, L.; Bitsch, I.; Bitsch, R.; Konczak, I. Cancer cell antiproliferation activity and metabolism of black carrot anthocyanins. Innov. Food Sci. Emerg. Technol. 2007, 8, 365–372. [Google Scholar] [CrossRef]
  65. Karkute, S.G.; Koley, T.K.; Yengkhom, B.K.; Tripathi, A.; Srivastava, S.; Maurya, A.; Singh, B. Anti-diabetic Phenolic Compounds of Black Carrot (Daucus carota Subspecies sativus var. atrorubens Alef.) Inhibit Enzymes of Glucose Metabolism: An in silico and in vitro Validation. Med. Chem. 2018, 14, 641–649. [Google Scholar] [CrossRef]
  66. Kaeswurm, J.A.H.; Könighofer, L.; Hogg, M.; Scharinger, A.; Buchweitz, M. Impact of B-Ring Substitution and Acylation with Hydroxy Cinnamic Acids on the Inhibition of Porcine α-Amylase by Anthocyanin-3-Glycosides. Foods 2020, 9, 367. [Google Scholar] [CrossRef] [Green Version]
  67. Kammerer, D.; Carle, R.; Schieber, A. Quantification of anthocyanins in black carrot extracts (Daucus carota ssp. sativus var. atrorubens Alef.) and evaluation of their color properties. Eur. Food Res. Technol. 2004, 219, 479–486. [Google Scholar] [CrossRef]
  68. Park, S.; Kang, S.; Jeong, D.-Y.; Jeong, S.-Y.; Kim, M.J. Black carrots fermented with Lactobacillus plantarum or Aspergillus oryzae prevent cognitive dysfunction by improving hippocampal insulin signalling in amyloid-β infused rats. J. Funct. Foods 2016, 25, 354–366. [Google Scholar] [CrossRef]
  69. Bhattacharya, S.; Rasmussen, M.K.; Christensen, L.P.; Young, J.F.; Kristiansen, K.; Oksbjerg, N. Naringenin and falcarinol stimulate glucose uptake and TBC1D1 phosphorylation in porcine myotube cultures. J. Biochem. Pharmacol. Res. 2014, 2, 91–98. [Google Scholar]
  70. Dragano, N.R.; Cintra, D.E.; Solon, C.; Morari, J.; Leite-Legatti, A.V.; Velloso, L.A.; Maróstica-Júnior, M.R. Freeze-dried jaboticaba peel powder improves insulin sensitivity in high-fat-fed mice. Br. J. Nutr. 2013, 110, 447–455. [Google Scholar] [CrossRef] [Green Version]
  71. Jennings, A.; Welch, A.A.; Fairweather-Tait, S.J.; Kay, C.; Minihane, A.M.; Chowienczyk, P.; Jiang, B.; Cecelja, M.; Spector, T.; Macgregor, A.; et al. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am. J. Clin. Nutr. 2012, 96, 781–788. [Google Scholar] [CrossRef] [Green Version]
  72. Ekinci, F.Y.; Baser, G.M.; Özcan, E.; Üstündağ, Ö.G.; Korachi, M.; Sofu, A.; Blumberg, J.B.; Chen, C.-Y.O. Characterization of chemical, biological, and antiproliferative properties of fermented black carrot juice, shalgam. Eur. Food Res. Technol. 2016, 242, 1355–1368. [Google Scholar] [CrossRef]
  73. Mannan, S. The Effect of Habitual Consumption of Anthocyanin-Rich Foodstuffs on Cardiovascular Health in At-Risk Individuals. Ph.D. Thesis, University of Guelph, Guelph, ON, USA, 2015; pp. 1–74. [Google Scholar]
  74. Buijsse, B.; Feskens, E.J.M.; Kwape, L.; Kok, F.J.; Kromhout, D. Both α- and β-Carotene, but Not Tocopherols and Vitamin C, Are Inversely Related to 15-Year Cardiovascular Mortality in Dutch Elderly Men. J. Nutr. 2008, 138, 344–350. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Wright, O.R.L.; Netzel, G.A.; Sakzewski, A.R. A randomized, double-blind, placebo-controlled trial of the effect of dried purple carrot on body mass, lipids, blood pressure, body composition, and inflammatory markers in overweight and obese adults: The QUENCH Trial. Can. J. Physiol. Pharmacol. 2013, 91, 480–488. [Google Scholar] [CrossRef] [PubMed]
  76. Blando, F.; Calabriso, N.; Berland, H.; Maiorano, G.; Gerardi, C.; Carluccio, M.; Andersen, Ø. Radical Scavenging and Anti-Inflammatory Activities of Representative Anthocyanin Groupings from Pigment-Rich Fruits and Vegetables. Int. J. Mol. Sci. 2018, 19, 169. [Google Scholar] [CrossRef] [Green Version]
  77. Butalla, A.C.; Crane, T.E.; Patil, B.; Wertheim, B.C.; Thompson, P.; Thomson, C.A. Effects of a Carrot Juice Intervention on Plasma Carotenoids, Oxidative Stress, and Inflammation in Overweight Breast Cancer Survivors. Nutr. Cancer 2012, 64, 331–341. [Google Scholar] [CrossRef]
  78. Jing, P.; Bomser, J.A.; Schwartz, S.J.; He, J.; Magnuson, B.A.; Giusti, M.M. Structure–Function Relationships of Anthocyanins from Various Anthocyanin-Rich Extracts on the Inhibition of Colon Cancer Cell Growth. J. Agric. Food Chem. 2008, 56, 9391–9398. [Google Scholar] [CrossRef]
  79. Kamiloglu, S.; Grootaert, C.; Capanoglu, E.; Ozkan, C.; Smagghe, G.; Raes, K.; Van Camp, J. Anti-inflammatory potential of black carrot (Daucus carota L.) polyphenols in a co-culture model of intestinal Caco-2 and endothelial EA.hy926 cells. Mol. Nutr. Food Res. 2017, 61, 1–11. [Google Scholar] [CrossRef]
  80. Kitano, A.; Norikura, T.; Matsui-Yuasa, I.; Shimakawa, H.; Kamezawa, M.; Kojima-Yuasa, A. Black Carrot (Daucus carota ssp. sativus var. atrorubens Alef.) Extract Protects against Ethanol-induced Liver Injury via the Suppression of Phosphodiesterase 4 mRNA Expression. Austin J. Nutr. Food Sci. 2021, 9, 1154. [Google Scholar] [CrossRef]
  81. Metzger, B.T.; Barnes, D.M.; Reed, J.D. Purple Carrot (Daucus carota L.) Polyacetylenes Decrease Lipopolysaccharide-Induced Expression of Inflammatory Proteins in Macrophage and Endothelial Cells. J. Agric. Food Chem. 2008, 56, 3554–3560. [Google Scholar] [CrossRef]
  82. Zaini, R.G.; Brandt, K.; R. Clench, M.; L. Le Maitre, C. Effects of Bioactive Compounds from Carrots (Daucus carota L.), Polyacetylenes, Beta-Carotene and Lutein on Human Lymphoid Leukaemia Cells. Anticancer. Agents Med. Chem. 2012, 12, 640–652. [Google Scholar] [CrossRef] [PubMed]
  83. Hamedi, S.; Koosha, M. Designing a pH-responsive drug delivery system for the release of black-carrot anthocyanins loaded in halloysite nanotubes for cancer treatment. Appl. Clay Sci. 2020, 197, 105770. [Google Scholar] [CrossRef]
  84. Pala, C.; Sevimli-Gur, C.; Yesil-Celiktas, O. Green Extraction Processes Focusing on Maximization of Black Carrot Anthocyanins along with Cytotoxic Activities. Food Anal. Methods 2017, 10, 529–538. [Google Scholar] [CrossRef]
  85. Zhao, X.; Feng, P.; He, W.; Du, X.; Chen, C.; Suo, L.; Liang, M.; Zhang, N.; Na, A.; Zhang, Y. The Prevention and Inhibition Effect of Anthocyanins on Colorectal Cancer. Curr. Pharm. Des. 2019, 25, 4919–4927. [Google Scholar] [CrossRef] [PubMed]
  86. Deding, U.; Baatrup, G.; Christensen, L.P.; Kobaek-Larsen, M. Carrot Intake and Risk of Colorectal Cancer: A Prospective Cohort Study of 57,053 Danes. Nutrients 2020, 12, 332. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Applsci 12 03170 g001 550
Figure 1. The factors affecting MetS and cancer.
Figure 1. The factors affecting MetS and cancer.
Applsci 12 03170 g001
Applsci 12 03170 g002 550
Figure 2. A graphical representation of the nutraceutical benefits of purple carrot against MetS and cancer.
Figure 2. A graphical representation of the nutraceutical benefits of purple carrot against MetS and cancer.
Applsci 12 03170 g002
Table
Table 1. The average nutritional values of purple carrot per 100 g.
Table 1. The average nutritional values of purple carrot per 100 g.
ComponentsNutritional ConcentrationReference
Energy42 kcal
Protein0.87 g
Fat0.14 g
Carbohydrates8.01 g[38]
Total dietary fiber2.48 g
Iron0.26 mg
Zinc0.15 mg
Sodium82 mg
Potassium256 mg
Calcium33 mg
Magnesium17 mg
Phosphorus29 mg
Vitamin B10.029 mg
Vitamin B20.029 mg
Vitamin B31.211 mg
Vitamin B60.072 mg
Table
Table 2. Bioactive components of the purple carrot.
Table 2. Bioactive components of the purple carrot.
Main GroupType of ComponentReferences
AnthocyaninsCyanidin-3-xylosyl-glucosyl-galactoside, cyanidin-3-xylosyl (coumaroylglucosyl) galactoside, cyanidin-3xylosyl (feruloylglucosyl) galactoside, cyanidin-3xylosyl (sinapoylglucosyl) galactoside, malvidin-3,5diglycosides, peonidin-3xylosylgalactoside, cyanidin-3-rutinosides, delphinidin-3-glucoside[45,46,47]
CarotenoidsLutein, zeaxanthin, α-carotene, 13-cis-β-carotene, β-carotene[47,48]
Polyacetylenes(Z)-heptadeca-1,9-diene-4,6-diyn-3-ol (falcarinol), (Z)-heptadeca-1,9-diene-4,6-diyne-3,8-diol (falcarindiol),
(Z)-3-acetoxyheptadeca-1,9-diene-4,6-diyn-8-ol (falcarindiol
3-acetate)		[49,50]
Phenolic acidsHydroxybenzoic, protocatecuic, gallic, syringic, chlorogenic, caffeic, cumaric, ferulic[42,47,51]
FlavonoidsFlavanones: erodictiol-7-O-glucoside, eriodictiol and naringenin-7-O-glucoside
Flavanols: Epicatechin and catechin
Flavonols: Kaempferol-3-O-rutinoside and quercetin-3-O-galactoside		[42]
Table
Table 3. The mechanism of purple carrot against MetS and cancer.
Table 3. The mechanism of purple carrot against MetS and cancer.
Main GroupActive
Component		MechanismReferences
Purple carrotAnthocyaninsPotential anti-diabetic properties, delay glucose absorption by inhibition of the enzymes α-amylase and α-glucosidase[53]
Purple carrot extractVimentinCause poor prognosis in human breast cancer without any side effects by radical scavenging activity[54]
Purple carrotDietary fiberReduction in the secretion of inflammatory biomarkers[38]
Purple carrot and its partsAnthocyaninsRegulate the markers of inflammation by reducing NF-KB signaling via different pathways[55]
Purple carrotCyanidin,
Malvidin		Markedly reduces the accumulation of fat (3T3-L1 cell lines of adipocytes) by reducing SREBP, reducing FAS and enhancing CPT-1[46]
Nuclear factor kappa light chain enhancer: NFKB; sterol regulatory element-binding protein-1c: SREBP; fatty acid synthase: FAS; carnitine palmitoyltransferase-1: CPT-1.
Table
Table 4. The impact of purple carrot consumption with regard to MetS and cancer.
Table 4. The impact of purple carrot consumption with regard to MetS and cancer.
Main GroupSubjectMaterial and MethodResultReferences
Purple carrot juiceRats5% of the whole dietReduced lipid profile, cardiac fibrosis, abdominal adiposity, blood pressure (systolic) hepatic steatosis, inflammatory markers and improved glucose tolerance[56]
A fermented extract of purple carrot by Aspergillus oryzaeEstrogen-deficient rats-Reduces energy impairment, lipid level and improves glucose metabolism[46]
Purple carrot extract (fermented with Lactobacillus Plantarum, Aspergillus Oryzae)Type 2 Diabetes in rats with dementiaDiet containing dextrin (2%), (ovariectomized-control group), purple carrot extract 2% (unfermented), 2% extract of purple carrot fermented by L. plantarum and 2% extract of purple carrot fermented by Aspergillus oryzae for 12 weeksImproved cognitive ability by improving hippocampal insulin resistance[68]
Dried purple carrotOverweight and obese adultsAnthocyanins (118.5 mg) and phenolic acids (259.2 mg) consumed each day for 4 weeksSignificant alterations in body composition, diet intake, total cholesterol, low-density lipoprotein levels, body composition, blood pressure, appetite, and C-reactive protein levels[75]
Purple carrot /Orange carrotIndividuals at risk of cardiovascular disease100 g of colored carrot, 2 times/day for 12 weeksPurple carrots enriched with anthocyanins may improve blood pressure (systolic and diastolic) and triglyceride levels[73]
Purple carrot and shalgam juice- Reduces the risk of cancer and CVD[72]
Purple carrot juiceAnimal modelJuice of purple carrot for thirty daysReduced SOD activity and blood triglyceride concentration, with no significant changes in plasma glucose[35]
Purple carrotHuman-Effective against diabetes; cyanidin 3-xylosyl galactoside is an ideal component for the inhibition of enzymes involved in glucose metabolism[65]
Purple carrot juice-Carrot juice (0.5 mg/mL, 0.7 mg/mL, and 1 mg/mL)The results showed increased glucose uptake and insulin activity[69]
Deep purple carrot (DPC)--An inhibitory effect was observed on α-glucosidase α-amylase and glucose uptake of cells, thus showing anti-diabetic potential[45]
Fresh carrot
Juice		Breast cancer survivors69, duration of 3 weeksThe result showed enhancement in plasma carotenoid levels and reductions in oxidative stress[77]
Lyophilized powder of anthocyanins of purple carrotHuman colorectal cancer cell lineDose: 0.0 to 2.0 mg/mL2.0 mg per mL anthocyanin concentration reduced the 80% growth of cancer cells (HT-29 and HL-60)[78]
Purple carrots--In a dose-dependent manner, reduced nitric oxide production by 65%, without causing any cytotoxicity, in addition to reducing inflammatory markers iNOS, TNF-α, IL-6, and IL-1β[81]
Purple carrot extract-Acetone and ethanol extracts (50 μg/mL)Exhibited 8.13% and 30.6% inhibition, respectively. This showed that D. carota extracts contain bioactive compounds that are effective against breast cancer proliferation.[37]
Young purple carrot shoot extracts-All calli and natural extractsAgainst neuro-2A cell line, an increased cytotoxic level was observed (capability of 38 to 46% at 6.25 μg/mL), and an increased IC50 value of 170.13 μg/mL was achieved in normal cells, suggesting that it is a principal component against brain cancer[54]
Purple carrot and its parts (peel and pomace)--Regulates the inflammatory response of TNF-α[38]
HNT of purple carrot--Anti-tumour activity was observed against breast cancer cell lines (HT-29 and MCF-7 cells) in contrast to pure anthocyanins[83]
Anthocyanin extract from purple carrot--The cytotoxic activity against breast carcinoma, alveolar adenocarcinoma, brain cancer, and osteosarcoma was significantly high, with IC50 values < 5.5 μg/mL[84]
Purple carrot extract--Reduces the onset of different oxidative stress-linked disorders[42]
Cardiovascular diseases: CVD; superoxide dismutase: SOD; nitric oxide synthase: iNOS; tumor necrosis factor-alpha; TNF-α; Interleukin-6: IL-6; Interleukin -1beta: IL-1β; Michigan Cancer Foundation-7: MCF-7; halloysite nanotubes: HNT; D. carota: Daucus carota; half-maximal inhibitory concentration: IC50; human leukemia: HL-60; human colorectal adenocarcinoma cell line: HT-29.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rasheed, H.; Shehzad, M.; Rabail, R.; Kowalczewski, P.Ł.; Kidoń, M.; Jeżowski, P.; Ranjha, M.M.A.N.; Rakha, A.; Din, A.; Aadil, R.M. Delving into the Nutraceutical Benefits of Purple Carrot against Metabolic Syndrome and Cancer: A Review. Appl. Sci. 2022, 12, 3170. https://doi.org/10.3390/app12063170

AMA Style

Rasheed H, Shehzad M, Rabail R, Kowalczewski PŁ, Kidoń M, Jeżowski P, Ranjha MMAN, Rakha A, Din A, Aadil RM. Delving into the Nutraceutical Benefits of Purple Carrot against Metabolic Syndrome and Cancer: A Review. Applied Sciences. 2022; 12(6):3170. https://doi.org/10.3390/app12063170

Chicago/Turabian Style

Rasheed, Hina, Maham Shehzad, Roshina Rabail, Przemysław Łukasz Kowalczewski, Marcin Kidoń, Paweł Jeżowski, Muhammad Modassar Ali Nawaz Ranjha, Allah Rakha, Ahmad Din, and Rana Muhammad Aadil. 2022. "Delving into the Nutraceutical Benefits of Purple Carrot against Metabolic Syndrome and Cancer: A Review" Applied Sciences 12, no. 6: 3170. https://doi.org/10.3390/app12063170

APA Style

Rasheed, H., Shehzad, M., Rabail, R., Kowalczewski, P. Ł., Kidoń, M., Jeżowski, P., Ranjha, M. M. A. N., Rakha, A., Din, A., & Aadil, R. M. (2022). Delving into the Nutraceutical Benefits of Purple Carrot against Metabolic Syndrome and Cancer: A Review. Applied Sciences, 12(6), 3170. https://doi.org/10.3390/app12063170

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop